期刊文献+

慢性牙周炎患者外周血T淋巴细胞表面程序性死亡分子1及其配体的表达 被引量:17

Expression of programmed death-1 and programmed death ligand-1 in the peripheral T-lymphocytes from patients with chronic periodontitis
原文传递
导出
摘要 目的 探讨慢性牙周炎患者外周血淋巴细胞程序性死亡分子1(programmed death-1,PD-1)及其主要配体程序性死亡分子配体1(programmed death ligand-1,PD-L1)的表达及其意义,以阐明其在慢性牙周炎发生和发展中的作用.方法 采用流式细胞术检测30例慢性牙周炎患者(牙周炎组)、25慢性牙龈炎患者(牙龈炎组)及18例牙周健康对照者(健康对照组)外周血CD4+和CD8+T淋巴细胞表面PD-1及PD-L1的表达,并检测16例慢性牙周炎患者进行牙周基础治疗6周后外周血CD4+和CD8+T淋巴细胞PD-1及PD-L1的表达.两组间比较采用t检验,多组间比较采用方差分析,多个样本间的两两比较采用LSD-t检验或x2检验.结果 牙周炎组外周血CD4+、CD8+T淋巴细胞表面PD-1的阳性表达率[(16.7±5.5)%、(20.8±5.1)%]及牙龈炎组二者的表达率[(14.2±6.1)%、(14.5±4.3)%]均显著高于健康对照组[分别为(9.5±2.1)%、(8.1±1.9)%](P值均<0.05);牙周炎组外周血CD4+、CD8+T淋巴细胞表面PD-L1的阳性表达率[(24.2±7.1)%、(15.3±6.8)%]及牙龈炎组二者的表达率[(12.4±6.0)%、(11.2±5.5)%]均显著高于健康对照组[(4.7±1.2)%和(3.2±2.3)%](P值均<0.05).牙周基础治疗6周后,16例慢性牙周炎患者CD4+和CD8+T淋巴细胞PD-1、PD-L1的阳性表达率均显著降低,与治疗前相比差异均有统计学意义(P值均<0.05).结论 慢性牙周炎患者外周血CD4+和CD8+T淋巴细胞PD-1及PD-L1表达水平显著升高,与牙周炎症水平密切相关,牙周基础治疗可以下调慢性牙周炎患者外周血CD4+和CD8+T细胞表面PD-1及PD-L1的表达. Objective To investigate the expression of programmed death-1(PD-1) and programmed death ligand-1 (PD-L1) in peripheral T-lymphocytes from patients with chronic periodontitis and its significance and to clarify its role in the development of chronic periodontitis.Methods A total of 73 subjects were included in the study and divided into three groups,chronic periodontitis (30 cases),chronic gingivitis(25 cases) and 18 healthy controls.The peripheral blood was collected and PD-1/PD-L1 expression in the surface of CD4+ T lymphocytes and CD8+ T lymphocytes was examined by flow cytometry.Blood samples from 16 chronic periodontitis patients were collected at week 0 and 6 after initial therapy for 6 weeks and PD-1 and PD-L1 expression in the surface of CD4+ and CD8+ T lymphocytes was also determined by flow cytometry.The data were statistically analyzed.Results The percentage of PD-1 expression in CD4+ and CD8+ T lymphocytes of chronic periodontitis group [(16.7 ± 5.5) %,(20.8 ± 5.1) %] and chronic gingivitis group [(14.2 ± 6.1) %,(14.5 ± 4.3) %] were higher than that of healthy controls [(9.5 ± 2.1) %,(8.1 ± 1.9) %] (P < 0.05).The percentage of PD-L1 expression in CD4+ and CD8+ T lymphocytes of chronic periodontitis group [(24.2 ± 7.1) %,(15.3 ± 6.8) %] and chronic gingivitis group [(12.4 ±6.0) %,(11.2 ± 5.5) %] were higher than that of healthy controls [(4.7 ± 1.2) %,(3.2 ± 2.3) %] (P < 0.05).The percentage of PD-1/PD-L1 expression in CD4+ T lymphocytes and CD8+ T lymphocytes of the chronic periodontitis group were significantly decreased after initial therapy(P < 0.05).Conclusions The expression of PD-1 and PD-L1 in peripheral CD4+ T lymphocytes and CD8+ T lymphocyte of chronic periodontitis patients was up-regulated and was associated with periodontal condition.The initial therapy reduced the expression of PD-1 and PD-L1.
出处 《中华口腔医学杂志》 CAS CSCD 北大核心 2014年第4期216-219,共4页 Chinese Journal of Stomatology
关键词 慢性牙周炎 T淋巴细胞 程序性死亡分子1 程序性死亡分子配体1 Chronic periodontitis T-lymphocytes Programmed death-1 Programmed death ligand-1
  • 相关文献

参考文献17

  • 1Khan N, Gowthaman U, Pahari S, et al. Manipulation of costimulatory molecules by intracellular pathogens: veni, vidi, vicill [J]. PLoS Pathog,2012,8(6) : e1002676. 6.
  • 2Okazaki T, Honjo T. PD-1 and PD-1 ligartds: from discovery to clinical application [ J ]. Int Immuno1,2007,19 (7) :813-824.
  • 3Keir ME, Butte MJ, Freeman GJ, et al. PD-1 and its ligands in tolerance and immunity [ J ] . Annu Rev Immunol, 2008, 26: 677-704.
  • 4Fife BT, Pauken KE. The role of the PD-1 pathway in autoimmunity and peripheral tolerance [ J ]. Ann N Y Aead Sei, 2011,1217:45-59.
  • 5Sznol M, Chen L Antagonist antibodies to PD-I and B7-H1 (PD-L1) in the treatment of advanced human cancer: response [ J]. Clin Cancer Res,2013,19 (19) :5542.
  • 6Figueira EA, de Rezende ML, Torres SA, et al. Inhibitory signals mediated by programmed death-1 are involved with T-cell function in chronic periodontitis [ J ] . J Periodontol, 2009, 80 ( 11 ) : 1833-1844.
  • 7Armitage GC. Development of a classification system for periodontal diseases and conditions [ J ]. Ann Periodontol, 1999,4 (1):1-6.
  • 8盂焕新.牙周病学[M].4版.北京:人民卫生出版社,2013:169-171.
  • 9束蓉,宋忠臣,葛琳华,顾晶晶,程岚,谢玉峰,李超伦,刘晓峰,刘大力.基础治疗对慢性牙周炎临床疗效和龈下牙周致病菌的影响[J].上海口腔医学,2010,19(3):225-227. 被引量:11
  • 10徐晓凤,叶金松,蒋丽华,陶岚,徐丽芳,刘灿均.重型肝炎患者T淋巴细胞PD-1/B_7-H_1通路的表达及意义[J].临床检验杂志,2011,29(9):670-671. 被引量:3

二级参考文献53

  • 1丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 2Jinfang Zhu Hidehiro Yamane Javier Cote-Sierra Liying Guo William E Paul.GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Thl cell-specific factors[J].Cell Research,2006,16(1):3-10. 被引量:49
  • 3孟焕新.牙周病学.3版.北京:人民卫生出版社,2008:227.
  • 4Makimura Y,Asai Y,Taiji Y,et al.Correlation between chemical structure and biological activities of Porphyromonas gingivalis synthetic lipopeptide derivatives.Clin Exp Immunol,2006,146(1):159-168.
  • 5Armitage GC.Development of a classification system for periodontal diseases and conditions.Ann Periodontol,1999,4(1):1-6.
  • 6O' Brien-Simpson NM,Pathirana RD,Walker CD,et al.Porphyromonas gingivalis RgpA-Kgp proteinase-adhesin complexes penetrate gingival tissue and induce proinflammatory cytokines or apoptosis in a concentration-dependent manner.Infect Immun,2009,77(3):1246-1261.
  • 7Kuboniwa M,Amano A,Hashino E,et al.Distinct roles of long/ short fimbriae and gingipains in homotypic biofilm development by Porphyromonas gingivalis.BMC Microbiol,2009,26(9):105.
  • 8Hashimoto M,Asai Y,Ogawa T.Separation and structural analysis of lipoprotein in a lipopolysaccharide preparation from Porphyromonas gingivalis.Int Immunol,2004,16(10):1431-1437.
  • 9Hasebe A,Yoshimura A,Into T,et al.Biological activities of Bacteroides forsythus lipoproteins and their possible pathological roles in periodontal disease.Infect Immun,2004,72(3);1318-1325.
  • 10Surdacka A. Strzyka AK, Rydzewska A, Changeability of oral carity environment[J]. Eur J Dent, 2007. 1(1):14-17.

共引文献33

同被引文献103

  • 1罗静洁.茶多酚含片预防骨科全麻术后患者口臭的临床观察[J].医学信息(医学与计算机应用),2014,0(5):190-191. 被引量:3
  • 2张微云,叶玮.茶多酚与维生素C联合应用抑制口腔产臭细菌产生挥发性硫化物的体外研究[J].中华临床医师杂志(电子版),2011,5(18):5462-5464. 被引量:16
  • 3Haidong Dong,Xianming Chen.Immunoregulatory Role of B7-H1 in Chronicity of Inflammatory Responses[J].Cellular & Molecular Immunology,2006,3(3):179-187. 被引量:25
  • 4Mahdi, Kadkhodazadeh Zahra, Baghani Ahmad Reza, etc. IL- 17 gene polymorphism is associated with chronic periodontitis and peri - implantitis in Iranian patients: a cross - sectional study [ J ]. Immunological investigations, 2013,42(2) : 156 - 163.
  • 5付刚,向元芳,陈勃,等.三种含漱液对口腔固定正畸患者牙周维护效果的临床对比研究[J].中国医药,2013,08(21):57-58.
  • 6付华,胡济安.茶多酚对牙周膜细胞的影响[J].国际口腔医学杂志,2013,33(10):685-686.
  • 7Akihiro, Yoshida Oum - Kehoum, Ennibi Hideo, ete. Quantitative diserimination of Aggregatibaeter aetino- mycetemcomitans highly leukotoxic JP2 clone from non - JP2 clones in diagnosis of aggressive periodontitis [ J]. BMC infectious diseases ,2012,12 ( 253 ) :3913 - 3914.
  • 8Li CL,Jiang YT,Liu da L,et al.Prevalence and quantification of the uncommon Archaea phylotype Thermoplasmata in chronic periodontitis[J].Archives of Oral Biology,2014,59(8):822-828.
  • 9Ourania-Menti,Goudouri Eleana,Kontonasaki Ulrich,et al.Antibacterial properties of metal and metalloid ions in chronic periodontitis and peri-implantitis therapy[J].Acta Biomaterialia,2014,10(8):3795-3810.
  • 10Boronat-Catal6 M, Catal-Pizarro M, Bag6n Sebasti6n JV. Salivary, and crevicular fluid interleukins in gingivitis [ J]. J Clin Exp Dem, 2014, 6 (2) : e175-e179.

引证文献17

二级引证文献99

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部